Varian Medical Syste
VAR
Delayed Nyse - 01/17 03:37:41 pm
108.815USD
+0.68%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period September 20172018
Sales2 6682 769
EBITDA-593
Operating profit (EBIT)437512
Pre-Tax Profit (EBT)--
Net income257381
EPS ( $ )2,754,11
Dividend per Share ( $ )--
Yield--
Announcement Date10/25/2017
08:02pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period September 20172018
Debt--
Finance366835
Operating income (EBITDA)-593
Leverage
(Debt/EBITDA)
--
Capital Expenditure59,174,4
Book Value Per Share (BVPS)--
Cash Flow per Share-6,63 $
Announcement Date10/25/2017
08:02pm
-
Balance Sheet Analysis
Financial Ratios
Size 2018e 2019e
Capitalization 9 902 M$ -
Entreprise Value (EV) 9 067 M$ 8 622 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 26,3x 24,2x
Capitalization / Revenue 3,58x 3,44x
EV / Revenue 3,27x 2,99x
EV / EBITDA 15,3x 13,7x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 18,5% 19,0%
operating Leverage (Delta EBIT / Delta Sales) 4,58x 1,69x
Net Margin (Net Profit / Revenue) 13,8% 14,2%
ROA (Net Profit / Asset) 12,0% 11,7%
ROE (Net Profit / Equities) 25,5% 21,8%
Rate of Dividend - -
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   2,69% 2,62%
Cash Flow / Sales 21,9% 20,0%
Capital Intensity (Assets / Sales) 1,15x 1,22x
Financial Leverage (Net Debt / EBITDA) -1,41x -2,03x
Price Earning Ratio
BNA & Dividende